Ssri examples
Pro Research Analysisby 
Searched over 200M research papers for "ssri examples"
Examples of Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of drugs commonly prescribed for the treatment of depression and various anxiety disorders. They function by increasing the levels of serotonin in the brain, which can help improve mood and reduce symptoms of depression and anxiety. Below are some examples of SSRIs, along with their specific characteristics and uses.
Common SSRIs and Their Characteristics
Fluoxetine
Fluoxetine is one of the most well-known SSRIs and is often prescribed for depression, obsessive-compulsive disorder (OCD), and panic disorder. It has a longer half-life compared to other SSRIs, which means it stays in the body longer and can lead to prolonged effects even after discontinuation1. Fluoxetine has been shown to be effective in reducing depression symptoms in both children and adolescents2.
Sertraline
Sertraline is another widely used SSRI, effective in treating depression, anxiety disorders, and PTSD. It is known for its relatively favorable side-effect profile and is often chosen for patients who may be sensitive to the side effects of other SSRIs9.
Paroxetine
Paroxetine is commonly prescribed for depression, generalized anxiety disorder, and social anxiety disorder. It has a shorter half-life than fluoxetine, which can lead to withdrawal symptoms if not tapered off properly9. Paroxetine is also associated with a higher risk of weight gain and sexual dysfunction compared to other SSRIs9.
Citalopram
Citalopram is used primarily for depression and has a relatively balanced side-effect profile. However, it has been shown to have limited effectiveness in treating autism spectrum disorders (ASD) in children, with some studies indicating potential harm6.
Escitalopram
Escitalopram, a derivative of citalopram, is often prescribed for depression and generalized anxiety disorder. It is known for its high efficacy and lower incidence of side effects compared to other SSRIs7. Short-term administration of escitalopram has been shown to enhance sensitivity to background outcomes and modulate response rates in learning tasks7.
Efficacy and Side Effects
Efficacy in Different Populations
SSRIs have been shown to be effective in treating a variety of conditions beyond depression, including OCD, panic disorder, and social phobia1. However, their efficacy can vary significantly among different populations. For instance, while fluoxetine has shown consistent effectiveness in children and adolescents, other SSRIs have not demonstrated the same level of efficacy2.
Side Effects and Tolerability
The side effects of SSRIs can vary depending on the specific drug and the individual patient. Common side effects include gastrointestinal issues, sexual dysfunction, and weight gain3. Genetic factors, such as polymorphisms in the serotonin transporter gene, can also influence the tolerability of SSRIs, with certain alleles being associated with a higher burden of adverse effects3.
Risks and Considerations
There are some risks associated with SSRI use, particularly in specific populations. For example, there is evidence suggesting that prenatal exposure to SSRIs may increase the risk of autism spectrum disorder (ASD) in offspring5. Additionally, SSRIs have been associated with an increased risk of suicidal ideation and behavior in children and adolescents, necessitating careful monitoring2.
Conclusion
SSRIs are a cornerstone in the treatment of depression and anxiety disorders, offering a range of options to suit different patient needs. Fluoxetine, sertraline, paroxetine, citalopram, and escitalopram are among the most commonly prescribed SSRIs, each with its own set of characteristics and side effects. While generally effective, the choice of SSRI should be tailored to the individual patient, taking into account their specific condition, genetic factors, and potential risks.
Sources and full results
Most relevant research papers on this topic
The SSRIs: advantages, disadvantages and differences
SSRIs offer better tolerability, reduced toxicity, and better treatment outcomes for depression, anxiety, and related disorders, but individual differences in side effects and drug interactions may impact treatment choices.
Highly CitedSelective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
SSRIs show potential in reducing depression symptoms in children and adolescents, but their effectiveness is limited by methodological issues and potential increased risk of suicidal outcomes.
Meta-AnalysisHighly CitedSerotonin transporter gene polymorphisms and SSRI tolerability: review of pharmacogenetic evidence
The S allele of 5-HTTLPR may predict increased adverse event burden during SSRI therapy, with the most convincing evidence in antidepressant-induced mania and gastrointestinal adverse events.
Systematic ReviewThe International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
Genetic variation in HPRTP4/VSTM5 and NRG1 may contribute to response to SSRI treatment for major depressive disorder, but no significant genome-wide associations were found.
Meta-Analysis
Very Rigorous JournalHighly CitedMaternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review
Prenatal exposure to SSRIs is associated with a higher risk of autism spectrum disorder in offspring.
Meta-Analysis
Rigorous JournalHighly CitedSelective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
SSRIs show no evidence of effectiveness in children with autism spectrum disorders and may cause harm, while limited evidence exists for their effectiveness in adults from small, unclear studies.
Meta-AnalysisVery Rigorous JournalHighly CitedSSRI enhances sensitivity to background outcomes and modulates response rates: A randomized double blind study of instrumental action and depression
Short-term SSRI administration (escitalopram) enhances sensitivity to background outcomes and modulates response rates, supporting perception of instrumental control in healthy individuals.
RCTEffects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis
SSRI treatment for major depressive disorder shows moderate immunomodulating effects, suggesting some of its therapeutic effect may be due to its anti-inflammatory properties.
Meta-AnalysisRigorous JournalHighly CitedHeterogeneity of SSRI Response
SSRIs are effective antidepressants with favorable side effects, but meaningful differences in therapeutic effect and side effects among them remain unclear.
Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial
Combining CBT and an SSRI with routine clinical care does not show evidence of improved outcomes by 28 weeks compared to routine care and an SSRI alone in adolescents with moderate to severe major depression.
RCTRigorous JournalHighly Cited